# FDA Inspection 1157825 - New York Blood Center Inc - October 15, 2021

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/3f9bf05b-4f28-40a9-baf7-3aaea3b849bc
Source feed: FDA_Inspections

> FDA Inspection 1157825 for New York Blood Center Inc on October 15, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1157825
- Company Name: New York Blood Center Inc
- Inspection Date: 2021-10-15
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312464 - 2026-04-02](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/df70605e-a594-47f4-b888-07666a8d8431)
- [FDA Inspection 1157825 - 2021-10-15](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/4d0951b4-facb-4468-ad03-86cbf4580fce)

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/8951900f-0d27-45b6-aadb-106e7cde603d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d